nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0456	0.0868	CcSEcCtD
Lovastatin—HDAC2—parathyroid gland—nephrolithiasis	0.0441	0.127	CbGeAlD
Lovastatin—UGT1A1—urine—nephrolithiasis	0.0358	0.103	CbGeAlD
Lovastatin—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0266	0.0506	CcSEcCtD
Lovastatin—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0234	0.0445	CcSEcCtD
Lovastatin—CYP2C19—urine—nephrolithiasis	0.0194	0.0558	CbGeAlD
Lovastatin—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0179	0.034	CcSEcCtD
Lovastatin—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0298	CcSEcCtD
Lovastatin—CYP2C9—urine—nephrolithiasis	0.0151	0.0433	CbGeAlD
Lovastatin—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.014	0.0266	CcSEcCtD
Lovastatin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0264	CcSEcCtD
Lovastatin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0126	0.024	CcSEcCtD
Lovastatin—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0237	CcSEcCtD
Lovastatin—CYP3A4—urine—nephrolithiasis	0.0115	0.033	CbGeAlD
Lovastatin—CYP2D6—urine—nephrolithiasis	0.0113	0.0325	CbGeAlD
Lovastatin—UGT2B7—renal system—nephrolithiasis	0.0103	0.0296	CbGeAlD
Lovastatin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0193	CcSEcCtD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—SLC7A9—nephrolithiasis	0.0101	0.0797	CbGpPWpGaD
Lovastatin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00997	0.019	CcSEcCtD
Lovastatin—UGT2B7—kidney—nephrolithiasis	0.00997	0.0287	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00995	0.0286	CbGeAlD
Lovastatin—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00988	0.0188	CcSEcCtD
Lovastatin—Injury—Hydrochlorothiazide—nephrolithiasis	0.0097	0.0185	CcSEcCtD
Lovastatin—HDAC2—nephron tubule—nephrolithiasis	0.00928	0.0267	CbGeAlD
Lovastatin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00925	0.0176	CcSEcCtD
Lovastatin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0175	CcSEcCtD
Lovastatin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00892	0.017	CcSEcCtD
Lovastatin—UGT1A1—renal system—nephrolithiasis	0.00877	0.0252	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00851	0.0245	CbGeAlD
Lovastatin—UGT1A1—kidney—nephrolithiasis	0.00847	0.0244	CbGeAlD
Lovastatin—HDAC2—renal system—nephrolithiasis	0.00844	0.0243	CbGeAlD
Lovastatin—HMGCR—nephron tubule—nephrolithiasis	0.00838	0.0241	CbGeAlD
Lovastatin—HDAC2—kidney—nephrolithiasis	0.00816	0.0235	CbGeAlD
Lovastatin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00803	0.0153	CcSEcCtD
Lovastatin—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00803	0.0153	CcSEcCtD
Lovastatin—HDAC2—cortex of kidney—nephrolithiasis	0.00794	0.0228	CbGeAlD
Lovastatin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00771	0.0147	CcSEcCtD
Lovastatin—HMGCR—renal system—nephrolithiasis	0.00761	0.0219	CbGeAlD
Lovastatin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00756	0.0144	CcSEcCtD
Lovastatin—HMGCR—kidney—nephrolithiasis	0.00736	0.0212	CbGeAlD
Lovastatin—SLCO1B1—renal system—nephrolithiasis	0.00729	0.021	CbGeAlD
Lovastatin—HMGCR—cortex of kidney—nephrolithiasis	0.00717	0.0206	CbGeAlD
Lovastatin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0071	0.0135	CcSEcCtD
Lovastatin—SLCO1B1—kidney—nephrolithiasis	0.00705	0.0203	CbGeAlD
Lovastatin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00704	0.0134	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00681	0.013	CcSEcCtD
Lovastatin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00674	0.0128	CcSEcCtD
Lovastatin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0127	CcSEcCtD
Lovastatin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00645	0.0123	CcSEcCtD
Lovastatin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00617	0.0117	CcSEcCtD
Lovastatin—ABCC2—nephron tubule—nephrolithiasis	0.00608	0.0175	CbGeAlD
Lovastatin—SLCO1A2—renal system—nephrolithiasis	0.00594	0.0171	CbGeAlD
Lovastatin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00583	0.0111	CcSEcCtD
Lovastatin—SLCO1A2—kidney—nephrolithiasis	0.00574	0.0165	CbGeAlD
Lovastatin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00573	0.0109	CcSEcCtD
Lovastatin—ABCC2—renal system—nephrolithiasis	0.00553	0.0159	CbGeAlD
Lovastatin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00545	0.0104	CcSEcCtD
Lovastatin—ABCC2—kidney—nephrolithiasis	0.00535	0.0154	CbGeAlD
Lovastatin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00529	0.0101	CcSEcCtD
Lovastatin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00526	0.01	CcSEcCtD
Lovastatin—ABCC2—cortex of kidney—nephrolithiasis	0.00521	0.015	CbGeAlD
Lovastatin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0052	0.00989	CcSEcCtD
Lovastatin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00983	CcSEcCtD
Lovastatin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00506	0.00963	CcSEcCtD
Lovastatin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00958	CcSEcCtD
Lovastatin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00948	CcSEcCtD
Lovastatin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00934	CcSEcCtD
Lovastatin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00922	CcSEcCtD
Lovastatin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00918	CcSEcCtD
Lovastatin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00915	CcSEcCtD
Lovastatin—ITGAL—Integrin cell surface interactions—SPP1—nephrolithiasis	0.00463	0.0366	CbGpPWpGaD
Lovastatin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00457	0.0087	CcSEcCtD
Lovastatin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00457	0.0087	CcSEcCtD
Lovastatin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00457	0.0087	CcSEcCtD
Lovastatin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00456	0.00867	CcSEcCtD
Lovastatin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00452	0.0086	CcSEcCtD
Lovastatin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00851	CcSEcCtD
Lovastatin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00442	0.00841	CcSEcCtD
Lovastatin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00834	CcSEcCtD
Lovastatin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00817	CcSEcCtD
Lovastatin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00795	CcSEcCtD
Lovastatin—CYP2C8—renal system—nephrolithiasis	0.00415	0.0119	CbGeAlD
Lovastatin—CYP3A5—nephron tubule—nephrolithiasis	0.00412	0.0118	CbGeAlD
Lovastatin—CYP2C8—kidney—nephrolithiasis	0.00401	0.0115	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00399	0.0076	CcSEcCtD
Lovastatin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00754	CcSEcCtD
Lovastatin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00749	CcSEcCtD
Lovastatin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00744	CcSEcCtD
Lovastatin—UGT1A3—Phase II conjugation—SLC26A1—nephrolithiasis	0.0039	0.0308	CbGpPWpGaD
Lovastatin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00734	CcSEcCtD
Lovastatin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00725	CcSEcCtD
Lovastatin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00719	CcSEcCtD
Lovastatin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00713	CcSEcCtD
Lovastatin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00713	CcSEcCtD
Lovastatin—CYP3A5—renal system—nephrolithiasis	0.00374	0.0108	CbGeAlD
Lovastatin—CYP3A5—kidney—nephrolithiasis	0.00362	0.0104	CbGeAlD
Lovastatin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00687	CcSEcCtD
Lovastatin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00682	CcSEcCtD
Lovastatin—CYP3A5—cortex of kidney—nephrolithiasis	0.00352	0.0101	CbGeAlD
Lovastatin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00663	CcSEcCtD
Lovastatin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00659	CcSEcCtD
Lovastatin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00659	CcSEcCtD
Lovastatin—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.00332	0.0262	CbGpPWpGaD
Lovastatin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00615	CcSEcCtD
Lovastatin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00599	CcSEcCtD
Lovastatin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0031	0.0059	CcSEcCtD
Lovastatin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.003	0.00571	CcSEcCtD
Lovastatin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00552	CcSEcCtD
Lovastatin—CYP3A4—renal system—nephrolithiasis	0.00281	0.00808	CbGeAlD
Lovastatin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00279	0.0053	CcSEcCtD
Lovastatin—CYP2D6—renal system—nephrolithiasis	0.00276	0.00795	CbGeAlD
Lovastatin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00526	CcSEcCtD
Lovastatin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00525	CcSEcCtD
Lovastatin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00523	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—SLC7A9—nephrolithiasis	0.00274	0.0216	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—DGKH—nephrolithiasis	0.00274	0.0216	CbGpPWpGaD
Lovastatin—CYP3A4—kidney—nephrolithiasis	0.00272	0.00781	CbGeAlD
Lovastatin—UGT1A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00269	0.0213	CbGpPWpGaD
Lovastatin—CYP2D6—kidney—nephrolithiasis	0.00267	0.00768	CbGeAlD
Lovastatin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00495	CcSEcCtD
Lovastatin—UGT1A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.0026	0.0205	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—SLC26A1—nephrolithiasis	0.00228	0.018	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00221	0.0175	CbGpPWpGaD
Lovastatin—ABCB1—nephron tubule—nephrolithiasis	0.00219	0.00629	CbGeAlD
Lovastatin—ITGAL—Focal Adhesion—SPP1—nephrolithiasis	0.00199	0.0157	CbGpPWpGaD
Lovastatin—ABCB1—renal system—nephrolithiasis	0.00199	0.00572	CbGeAlD
Lovastatin—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00194	0.0153	CbGpPWpGaD
Lovastatin—ABCB1—kidney—nephrolithiasis	0.00192	0.00553	CbGeAlD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00188	0.0149	CbGpPWpGaD
Lovastatin—ABCB1—cortex of kidney—nephrolithiasis	0.00187	0.00538	CbGeAlD
Lovastatin—UGT1A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.0018	0.0142	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00175	0.0138	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00172	0.0136	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00172	0.0136	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00161	0.0127	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00158	0.0124	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—SPP1—nephrolithiasis	0.00153	0.0121	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00147	0.0116	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00147	0.0116	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00133	0.0105	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00131	0.0103	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00131	0.0103	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00121	0.00958	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00121	0.00958	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00112	0.00881	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00112	0.00881	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00108	0.00854	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00107	0.00847	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00107	0.00847	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00104	0.00819	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00104	0.00819	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000978	0.00772	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000978	0.00772	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.000958	0.00756	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000957	0.00755	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000925	0.0073	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000918	0.00725	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000918	0.00725	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000875	0.00691	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000875	0.00691	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000872	0.00688	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SLC7A9—nephrolithiasis	0.000841	0.00664	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—DGKH—nephrolithiasis	0.000841	0.00664	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00083	0.00655	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000819	0.00646	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000797	0.00629	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000797	0.00629	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—SPP1—nephrolithiasis	0.000781	0.00616	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000749	0.00591	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000749	0.00591	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000741	0.00585	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000681	0.00538	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000676	0.00533	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000663	0.00524	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000663	0.00524	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GRHPR—nephrolithiasis	0.000632	0.00498	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000617	0.00487	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000617	0.00487	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000604	0.00477	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000604	0.00477	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000567	0.00448	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000567	0.00448	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AGXT—nephrolithiasis	0.000563	0.00444	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000562	0.00443	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000562	0.00443	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00055	0.00434	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00055	0.00434	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000527	0.00416	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000527	0.00416	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GRHPR—nephrolithiasis	0.000515	0.00406	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000501	0.00395	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000501	0.00395	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADCY10—nephrolithiasis	0.000497	0.00392	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SLC26A1—nephrolithiasis	0.000479	0.00378	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—APRT—nephrolithiasis	0.000479	0.00378	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00047	0.00371	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00047	0.00371	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00046	0.00363	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00046	0.00363	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AGXT—nephrolithiasis	0.000459	0.00362	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SLC26A1—nephrolithiasis	0.000457	0.00361	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000446	0.00352	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000439	0.00347	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.000438	0.00345	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RGS14—nephrolithiasis	0.000422	0.00333	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00041	0.00323	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ATP6V0A4—nephrolithiasis	0.000407	0.00321	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0004	0.00316	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SLC26A1—nephrolithiasis	0.00039	0.00308	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.00039	0.00308	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—APRT—nephrolithiasis	0.00039	0.00308	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.000381	0.00301	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000376	0.00297	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000375	0.00296	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000375	0.00296	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GRHPR—nephrolithiasis	0.000356	0.00281	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AQP1—nephrolithiasis	0.000341	0.00269	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.00034	0.00268	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000332	0.00262	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000332	0.00262	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.000326	0.00257	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AGXT—nephrolithiasis	0.000317	0.0025	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CHRM3—nephrolithiasis	0.000308	0.00243	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000299	0.00236	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.000291	0.00229	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.000289	0.00228	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.000289	0.00228	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000285	0.00225	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DGKH—nephrolithiasis	0.000285	0.00225	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000284	0.00224	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000284	0.00224	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AQP1—nephrolithiasis	0.000278	0.00219	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SLC26A1—nephrolithiasis	0.00027	0.00213	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APRT—nephrolithiasis	0.00027	0.00213	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000267	0.0021	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000264	0.00208	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000264	0.00208	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CHRM3—nephrolithiasis	0.000251	0.00198	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000247	0.00195	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000247	0.00195	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000236	0.00187	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000235	0.00186	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000235	0.00186	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000227	0.00179	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000227	0.00179	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000216	0.00171	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.000214	0.00169	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CHRM3—nephrolithiasis	0.000206	0.00163	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AQP1—nephrolithiasis	0.000206	0.00162	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000193	0.00152	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AQP1—nephrolithiasis	0.000192	0.00152	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTH—nephrolithiasis	0.000189	0.00149	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000188	0.00148	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000187	0.00148	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	0.000186	0.00147	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000176	0.00139	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CHRM3—nephrolithiasis	0.000174	0.00137	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000167	0.00132	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000167	0.00132	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000164	0.00129	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000164	0.00129	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000163	0.00129	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000162	0.00127	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000159	0.00126	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000154	0.00121	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000152	0.0012	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000149	0.00118	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000146	0.00115	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000145	0.00115	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000142	0.00112	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000142	0.00112	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000137	0.00108	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000136	0.00107	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000127	0.001	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000127	0.001	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000124	0.000976	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000124	0.000976	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000117	0.000922	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000117	0.00092	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000117	0.00092	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000116	0.000912	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000116	0.000912	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000106	0.000833	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000101	0.000798	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000101	0.000793	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SPP1—nephrolithiasis	9.47e-05	0.000747	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CHRM3—nephrolithiasis	9.15e-05	0.000722	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AQP1—nephrolithiasis	9.03e-05	0.000713	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.96e-05	0.000707	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AQP1—nephrolithiasis	8.81e-05	0.000695	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AQP1—nephrolithiasis	8.3e-05	0.000655	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AQP1—nephrolithiasis	8.23e-05	0.00065	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CHRM3—nephrolithiasis	8.16e-05	0.000644	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.97e-05	0.000629	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APRT—nephrolithiasis	7.62e-05	0.000601	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	7.62e-05	0.000601	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CHRM3—nephrolithiasis	7.51e-05	0.000593	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CHRM3—nephrolithiasis	7.44e-05	0.000588	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AQP1—nephrolithiasis	5.43e-05	0.000428	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.91e-05	0.000387	CbGpPWpGaD
